Rigel Pharmaceuticals Inc (RIGL)
1.05
-0.02
(-1.87%)
USD |
NASDAQ |
Apr 30, 16:00
1.05
0.00 (0.00%)
After-Hours: 18:40
Rigel Pharmaceuticals Free Cash Flow: -20.74M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -20.74M |
| September 30, 2023 | -36.48M |
| June 30, 2023 | -48.62M |
| March 31, 2023 | -67.42M |
| December 31, 2022 | -74.21M |
| September 30, 2022 | -71.29M |
| June 30, 2022 | -68.27M |
| March 31, 2022 | -0.584M |
| December 31, 2021 | 5.251M |
| September 30, 2021 | 8.24M |
| June 30, 2021 | -0.97M |
| March 31, 2021 | -69.77M |
| December 31, 2020 | -53.45M |
| September 30, 2020 | -47.63M |
| June 30, 2020 | -42.95M |
| March 31, 2020 | -45.72M |
| December 31, 2019 | -42.96M |
| September 30, 2019 | -21.13M |
| June 30, 2019 | -26.38M |
| March 31, 2019 | -37.29M |
| December 31, 2018 | -59.93M |
| September 30, 2018 | -91.28M |
| June 30, 2018 | -88.70M |
| March 31, 2018 | -80.51M |
| December 31, 2017 | -77.72M |
| Date | Value |
|---|---|
| September 30, 2017 | -70.42M |
| June 30, 2017 | -75.58M |
| March 31, 2017 | -74.76M |
| December 31, 2016 | -76.69M |
| September 30, 2016 | -78.15M |
| June 30, 2016 | -65.10M |
| March 31, 2016 | -64.66M |
| December 31, 2015 | -23.96M |
| September 30, 2015 | -25.23M |
| June 30, 2015 | -33.80M |
| March 31, 2015 | -35.60M |
| December 31, 2014 | -70.17M |
| September 30, 2014 | -74.03M |
| June 30, 2014 | -76.57M |
| March 31, 2014 | -78.12M |
| December 31, 2013 | -87.30M |
| September 30, 2013 | -90.40M |
| June 30, 2013 | -89.54M |
| March 31, 2013 | -89.53M |
| December 31, 2012 | -88.59M |
| September 30, 2012 | -85.25M |
| June 30, 2012 | -78.60M |
| March 31, 2012 | -74.90M |
| December 31, 2011 | -71.68M |
| September 30, 2011 | -43.50M |
Free Cash Flow Range, Past 5 Years
-74.21M
Minimum
Dec 2022
8.24M
Maximum
Sep 2021
-38.16M
Average
-42.96M
Median
Dec 2019
Free Cash Flow Benchmarks
| Nektar Therapeutics | -193.47M |
| Avid Bioservices Inc | -38.50M |
| Stereotaxis Inc | -9.505M |
| Cara Therapeutics Inc | -94.45M |
| Blueprint Medicines Corp | -452.91M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.24M |
| Cash from Investing (Quarterly) | -6.874M |
| Cash from Financing (Quarterly) | 0.486M |
| Free Cash Flow Per Share (Quarterly) | -0.0358 |
| Free Cash Flow to Equity (Quarterly) | -6.183M |
| Free Cash Flow Yield | -11.35% |